{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Qiao W"],"funding":["Beijing You'an Hospital Affiliated to Capital Medical University Incubation Program for Young and Middle aged Talents","Beijing You&apos;an Hospital Affiliated to Capital Medical University Incubation Program for Young and Middle aged Talents"],"pagination":["241"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11076334"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["150(5)"],"pubmed_abstract":["<h4>Background</h4>Currently, the high recurrence rate still forms severe challenges in hepatocellular carcinoma (HCC) treatment. The GALAD score, including age, gender, alpha-fetoprotein (AFP), lens culinaris agglutinin-reactive AFP (AFP-L3), and des-gamma-carboxyprothrombin (DCP) was developed as a diagnostic model. However, evidence is still lacking to confirm the capability of the GALAD score to predict the recurrence of HCC.<h4>Methods</h4>This study included 390 HCC patients after local ablation at Beijing You'an Hospital from January 1, 2018, to December 31, 2022. Firstly, the area under the receiver operating characteristic (ROC) curve (AUC) was calculated to assess the predictive capability of the GALAD score. Then, the Kaplan-Meier (KM) curve and log-rank test were used to compar"],"journal":["Journal of cancer research and clinical oncology"],"pubmed_title":["GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation."],"pmcid":["PMC11076334"],"funding_grant_id":["BJYAYY-YN2022-25"],"pubmed_authors":["Qiao W","Xiong Y","Zheng J","Hu C","Li J","Jin R"],"additional_accession":[]},"is_claimable":false,"name":"GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation.","description":"<h4>Background</h4>Currently, the high recurrence rate still forms severe challenges in hepatocellular carcinoma (HCC) treatment. The GALAD score, including age, gender, alpha-fetoprotein (AFP), lens culinaris agglutinin-reactive AFP (AFP-L3), and des-gamma-carboxyprothrombin (DCP) was developed as a diagnostic model. However, evidence is still lacking to confirm the capability of the GALAD score to predict the recurrence of HCC.<h4>Methods</h4>This study included 390 HCC patients after local ablation at Beijing You'an Hospital from January 1, 2018, to December 31, 2022. Firstly, the area under the receiver operating characteristic (ROC) curve (AUC) was calculated to assess the predictive capability of the GALAD score. Then, the Kaplan-Meier (KM) curve and log-rank test were used to compar","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 May","modification":"2026-04-08T19:48:58.85Z","creation":"2026-04-08T14:33:17.039Z"},"accession":"S-EPMC11076334","cross_references":{"pubmed":["38713414"],"doi":["10.1007/s00432-024-05760-z"]}}